Connections

Work with your personal adviser to grow your wealth

Jeremy Sullivan

NZ Equity Focus – EBOS

FINANCIAL PERFORMANCE: SEGMENT PERFORMANCE: STRATEGIC INVESTMENTS AND ACQUISITIONS: FINANCIAL METRICS: OUTLOOK FOR FY25: SUSTAINABILITY AND ESG INITIATIVES: SHARE PRICE PERFORMANCE: Conclusion: The announcement from EBOS is largely positive, showcasing strong financial performance, strategic growth through acquisitions, and continued investment in its core segments. Despite the anticipated impact of the CWA

Read More

Summerset vs Ryman Healthcare

Summerset often gets compared with Ryman Healthcare. They both operate and develop retirement villages here and in Australia. However, their share prices have been anything but similar over the past 10 years. Every $1,000 invested into Summerset in 2014 is now worth $3,270. For Ryman, every $1,000 is now worth

Read More

Genesis Energy: A new beginning

Genesis Energy has a plan to significantly increase its use of renewable energy by 2035. The company intends to utilise profits from the Kupe gas field to fund a $1.1 billion program dedicated to constructing new renewable energy sources and large-scale battery storage by 2030. In this strategy reset, known

Read More

Market Commentary

January was the second worst month on the NZX50 since February 2008 The reason for this reduction in prices is primarily due to increasing interest rates. The geopolitical situation between Russia on the Ukraine deteriorated. Global sanctions on Russia have driven up the prices of a number of commodities, namely

Read More

NZ Company Update – Fisher & Paykel Healthcare

Last Price: $26.10 NZD Sector: Healthcare Market Cap: $14.48Bn NZD Company Description Fisher and Paykel Healthcare is currently New Zealand’s largest listed company and is up an incredible 93.85% since the beginning of 2019. They are a global leader in medical devices and systems for use in respiratory care, acute

Read More

Orion Health’s fading star – with Jeremy Sullivan

For this weekend’s feature business article in the New Zealand Herald, Jeremy Sullivan chats with Holly Ryan on the rise and fall of former market darling Orion Health. It had “huge growth potential”, “elegant products”, a share price that topped $6 and a market value of more than $1 billion.

Read More